Financial News
Acadia Pharmaceutica (NQ: ACAD )
17.88
+0.13
(+0.73%)
Streaming Delayed Price
Updated: 12:18 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Acadia Pharmaceutica
![](https://mms.businesswire.com/media/20230303005382/en/1736019/5/Acadia_Reg_rgb_primary_gradient_R_mark.jpg)
![](https://g.foolcdn.com/editorial/images/723274/cleanroom.jpg)
![](https://mms.businesswire.com/media/20230303005417/en/1510725/22/Latest_KSF_SEC.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/28/acad_logo_light__1eb578dd5218f06affd93c334493da6d.png?width=1200&height=800&fit=crop)
Analysts See Steady Growth For Acadia Pharma's Nuplazid
February 28, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
What 10 Analyst Ratings Have To Say About ACADIA Pharmaceuticals
February 28, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Preview For ACADIA Pharmaceuticals
February 24, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for ACADIA Pharmaceuticals's Future
January 31, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_2686.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230227005643/en/826635/5/Acadia_new_logo_2020.jpg)
![](https://mms.businesswire.com/media/20230214005788/en/826635/5/Acadia_new_logo_2020.jpg)
![](https://mms.businesswire.com/media/20230213005611/en/826635/5/Acadia_new_logo_2020.jpg)
![](https://mms.businesswire.com/media/20230109005307/en/826635/5/Acadia_new_logo_2020.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_130.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230103005162/en/826635/5/Acadia_new_logo_2020.jpg)
![](https://mms.businesswire.com/media/20221221005543/en/826635/5/Acadia_new_logo_2020.jpg)
![](https://mms.businesswire.com/media/20221125005382/en/1510725/4/Latest_KSF_SEC.jpg)
Acadia Trofinetide Phase III Clinical Top-Line Results Positive
November 16, 2022
Via AB Newswire
![](https://mms.businesswire.com/media/20221108006174/en/826635/5/Acadia_new_logo_2020.jpg)
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
November 08, 2022
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_29167.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
November 04, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20221102005797/en/826635/5/Acadia_new_logo_2020.jpg)
Acadia Pharmaceuticals Reports Third Quarter 2022 Financial Results
November 02, 2022
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6692.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20221031005844/en/1510725/4/Latest_KSF_SEC.jpg)
![](https://mms.businesswire.com/media/20221027006016/en/826635/5/Acadia_new_logo_2020.jpg)
![](https://mms.businesswire.com/media/20221020005244/en/826635/5/Acadia_new_logo_2020.jpg)
![](https://mms.businesswire.com/media/20221013005276/en/1600697/4/B612_20220614_152843_887.jpg)
![](https://mms.businesswire.com/media/20221004005345/en/826635/5/Acadia_new_logo_2020.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/12/bz-pharma_5.jpg?width=1200&height=800&fit=crop)
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/12/bz-pharma_0.jpg?width=1200&height=800&fit=crop)
U.S. FDA Accepts Acadia's Filing For Rett Syndrome Candidate Under Priority Review
September 12, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.